AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $365,000 | +6.7% | 38,780 | -13.2% | 0.00% | 0.0% |
Q2 2020 | $342,000 | +37.3% | 44,694 | +10.6% | 0.00% | 0.0% |
Q1 2020 | $249,000 | -49.0% | 40,415 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $488,000 | +1.5% | 40,415 | -16.1% | 0.00% | 0.0% |
Q2 2019 | $481,000 | -22.4% | 48,184 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $620,000 | -1.4% | 48,184 | +7.3% | 0.00% | 0.0% |
Q4 2018 | $629,000 | -21.4% | 44,924 | +12.3% | 0.00% | 0.0% |
Q3 2018 | $800,000 | -8.6% | 40,005 | -11.1% | 0.00% | 0.0% |
Q2 2018 | $875,000 | -3.4% | 45,019 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $906,000 | +52.5% | 45,019 | 0.0% | 0.00% | +100.0% |
Q4 2017 | $594,000 | -31.6% | 45,019 | -8.0% | 0.00% | -50.0% |
Q3 2017 | $869,000 | -3.2% | 48,946 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $898,000 | -14.6% | 48,946 | +4.7% | 0.00% | -33.3% |
Q1 2017 | $1,052,000 | -32.8% | 46,746 | +3.8% | 0.00% | -25.0% |
Q4 2016 | $1,565,000 | -29.1% | 45,022 | -50.0% | 0.00% | +33.3% |
Q3 2016 | $2,208,000 | +105.2% | 90,044 | +100.0% | 0.00% | 0.0% |
Q2 2016 | $1,076,000 | +1415.5% | 45,022 | +1374.7% | 0.00% | – |
Q1 2016 | $71,000 | -22.8% | 3,053 | 0.0% | 0.00% | – |
Q4 2015 | $92,000 | -24.6% | 3,053 | 0.0% | 0.00% | – |
Q3 2015 | $122,000 | -92.5% | 3,053 | -87.0% | 0.00% | -100.0% |
Q2 2015 | $1,624,000 | +1955.7% | 23,553 | +1521.0% | 0.01% | – |
Q1 2015 | $79,000 | +27.4% | 1,453 | 0.0% | 0.00% | – |
Q4 2014 | $62,000 | -48.3% | 1,453 | -61.3% | 0.00% | – |
Q3 2014 | $120,000 | – | 3,753 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |